Cargando…

Antibody Focusing to Conserved Sites of Vulnerability: The Immunological Pathways for ‘Universal’ Influenza Vaccines

Influenza virus remains a serious public health burden due to ongoing viral evolution. Vaccination remains the best measure of prophylaxis, yet current seasonal vaccines elicit strain-specific neutralizing responses that favor the hypervariable epitopes on the virus. This necessitates yearly reformu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sangesland, Maya, Lingwood, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914524/ https://www.ncbi.nlm.nih.gov/pubmed/33562627 http://dx.doi.org/10.3390/vaccines9020125

Ejemplares similares

Public Immunity: Evolutionary Spandrels for Pathway-Amplifying Protective Antibodies
por: Sangesland, Maya, et al.
Publicado: (2021)

Modeling and Manipulating Antibody Response Against Influenza and Coronavirus Spike Proteins and Exploring their Role in Directing Spike Evolution
por: Amitai, Assaf, et al.
Publicado: (2021)

Antibody-mediated NK cell activation as a correlate of immunity against influenza infection
por: Boudreau, Carolyn M., et al.
Publicado: (2023)

Development of Universal Influenza Vaccines Targeting Conserved Viral Proteins
por: Jazayeri, Seyed Davoud, et al.
Publicado: (2019)

Influenza vaccination: protecting the most vulnerable
por: Tanner, Alex R., et al.
Publicado: (2021)

Humoral responses to the SARS-CoV-2 spike and receptor binding domain in context of pre-existing immunity confer broad sarbecovirus neutralization
por: Hauser, Blake M., et al.
Publicado: (2022)

Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development
por: Staneková, Zuzana, et al.
Publicado: (2010)

Uncovering a conserved vulnerability site in SARS‐CoV‐2 by a human antibody
por: Li, Tingting, et al.
Publicado: (2021)

A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies
por: Wang, Chunyan, et al.
Publicado: (2021)

Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprinting
por: Hauser, Blake M., et al.
Publicado: (2022)

Systems Immunology: Revealing Influenza Immunological Imprint
por: Tomic, Adriana, et al.
Publicado: (2021)

Protective Immunity Based on the Conserved Hemagglutinin Stalk Domain and Its Prospects for Universal Influenza Vaccine Development
por: Khanna, Madhu, et al.
Publicado: (2014)

Progress in the Development of Universal Influenza Vaccines
por: Sun, Wenqiang, et al.
Publicado: (2020)

Influenza and Universal Vaccine Research in China
por: Li, Jiali, et al.
Publicado: (2022)

Neutralizing Antibodies Targeting the Conserved Stem Region of Influenza Hemagglutinin
por: Nath Neerukonda, Sabari, et al.
Publicado: (2020)

Pre-existing Fc profiles shape the evolution of neutralizing antibody breadth following influenza vaccination
por: Boudreau, Carolyn M., et al.
Publicado: (2023)

A Single Human V(H)-gene Allows for a Broad-Spectrum Antibody Response Targeting Bacterial Lipopolysaccharides in the Blood
por: Sangesland, Maya, et al.
Publicado: (2020)

Potential of conserved antigenic sites in development of universal SARS-like coronavirus vaccines
por: Wang, Siling, et al.
Publicado: (2022)

Prospects and Challenges in the Development of Universal Influenza Vaccines
por: Madsen, Anders, et al.
Publicado: (2020)

Targeting Antigens for Universal Influenza Vaccine Development
por: Nguyen, Quyen-Thi, et al.
Publicado: (2021)

Antibodies Against Conserved Antigens Provide Opportunities for Reform in Influenza Vaccine Design
por: Kaminski, Denise A., et al.
Publicado: (2011)

The Next Generation of Influenza Vaccines: Towards a Universal Solution
por: McMillan, Christopher L.D., et al.
Publicado: (2021)

Evolutionary conservation and positive selection of influenza A nucleoprotein CTL epitopes for universal vaccination
por: McGee, Michael C., et al.
Publicado: (2022)

Cross-Lineage Influenza B and Heterologous Influenza A Antibody Responses in Vaccinated Mice: Immunologic Interactions and B/Yamagata Dominance
por: Skowronski, Danuta M., et al.
Publicado: (2012)

Prospects of HA-Based Universal Influenza Vaccine
por: Hashem, Anwar M.
Publicado: (2015)

Nano/microparticle Formulations for Universal Influenza Vaccines
por: Hendy, Dylan A., et al.
Publicado: (2022)

Universal Influenza Vaccines, a Dream to Be Realized Soon
por: Zhang, Han, et al.
Publicado: (2014)

Options and Obstacles for Designing a Universal Influenza Vaccine
por: Jang, Yo Han, et al.
Publicado: (2014)

Computational Approaches and Challenges to Developing Universal Influenza Vaccines
por: Qiu, Xueting, et al.
Publicado: (2019)

Influenza–Host Interplay and Strategies for Universal Vaccine Development
por: Hwang, Hye Suk, et al.
Publicado: (2020)

Strategies Targeting Hemagglutinin as a Universal Influenza Vaccine
por: Bullard, Brianna L., et al.
Publicado: (2021)

Progress towards the Development of a Universal Influenza Vaccine
por: Wang, Wen-Chien, et al.
Publicado: (2022)

Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody
por: Raymond, Donald D., et al.
Publicado: (2018)

Immunologic checkpoints in cancer therapy: focus on the programmed death-1 (PD-1) receptor pathway
por: Momtaz, Parisa, et al.
Publicado: (2014)

Immunologic Pathophysiology and Airway Remodeling Mechanism in Severe Asthma: Focused on IgE-Mediated Pathways
por: Cheng, Shih-Lung
Publicado: (2021)

Structural and genetic basis for development of broadly neutralizing influenza antibodies
por: Lingwood, Daniel, et al.
Publicado: (2012)

The persistence of interleukin-6 is regulated by a blood buffer system derived from dendritic cells
por: Yousif, Ashraf S., et al.
Publicado: (2021)

Towards universal influenza vaccines?
por: Osterhaus, Ab, et al.
Publicado: (2011)

Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head
por: Wiersma, Lidewij C. M., et al.
Publicado: (2015)

M2e-Based Universal Influenza A Vaccines
por: Deng, Lei, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_itlouilrkk0u50vcckespnfj44